SINOVAC is committed to developing and innovating cutting-edge vaccines to meet the challenge of preventing human diseases worldwide. SINOVAC has mastered multiple core vaccine technologies and boasts an R&D system made up of seven diverse technology platforms that fuel product development for viral and bacterial vaccines, attenuated live vaccines, recombinant protein vaccines, antibodies, and mRNA vaccines. These platforms are supported by world-class facilities that carry out advanced molecular and cellular biology, immunology, and biochemical analysis, as well as large-scale, animal-based research. Our strong interdisciplinary research team includes experts in pharmacy, biology, medicine, and chemistry, who support a robust capacity for research, development, and innovation.